Dr Justin M Magalassi, DO | |
3401 W Gore Blvd, Lawton, OK 73505-6332 | |
(918) 519-2011 | |
Not Available |
Full Name | Dr Justin M Magalassi |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 3401 W Gore Blvd, Lawton, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073996682 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 0002761787 (Oklahoma) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Justin M Magalassi, DO 3401 W Gore Blvd, Lawton, OK 73505-6332 Ph: (918) 519-2011 | Dr Justin M Magalassi, DO 3401 W Gore Blvd, Lawton, OK 73505-6332 Ph: (918) 519-2011 |
News Archive
The relationship between body mass index (BMI) appears to be stronger in adults without diabetes than those with existing diabetes. These findings- are published in the Journal of General Internal Medicine- in a study by Chandra Jackson of the Harvard School of Public Health and colleagues.
Scientists in the Academy of Finland's Neuroscience Research Programme have reported promising new results with potential implications for the treatment of Parkinson's disease. They have been studying the impacts of nerve growth factors in the treatment of PD, and their latest results show that a certain growth factor can be used to halt the progress of damage brought on by a nerve poison and possibly even restore the function of damaged cells.
Phase 1 trial results published in The Lancet Infectious Diseases found a new subunit vaccine —an MF59-adjuvanted subunit vaccine using recombinant spike glycoprotein stabilized in a prefusion conformation by a novel molecular clamp — targeting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was safe and effective in producing an antigen-specific response in healthy adults.
NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective market with first-in-class compounds such as its proprietary Aganocides®, today announced that the World Health Organization (WHO) has approved the international nonproprietary name (INN) "auriclosene" (pronounced awr-rih-CLO-zeen) for the Company's lead Aganocide® compound NVC-422.
› Verified 1 days ago
Daniel Dorton, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3401 W Gore Blvd # W, Lawton, OK 73505 Phone: 580-699-4322 | |
Dr. Kirk M. Smith, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4909 Se Mills Ave, Lawton, OK 73501 Phone: 580-890-0545 | |
Dr. Manuel Delarosa, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 20 Nw 67th St, Suite E, Lawton, OK 73505 Phone: 580-536-9400 | |
Ryan Dale Ford, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4510 Sw Wendy Dr, Lawton, OK 73505 Phone: 580-355-8620 | |
Dr. Andrew Burnette, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3401 W Gore Blvd, Lawton, OK 73505 Phone: 580-585-5545 | |
David W. Behm, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5602 Sw Lee Blvd, Er Dept, Lawton, OK 73505 Phone: 580-531-4700 Fax: 405-749-4561 |